Healthcare: Are We on the Cusp of a Big Alzheimer's Disease Breakthrough?

Industry Focus - Un pódcast de The Motley Fool

Categorías:

Promo: Biogen and Eisai rolled out encouraging data for one of their Alzheimer's disease drugs last week. Also, why is Amazon.com's purchase of PillPack so important? Stocks: BIIB, AMZN, WBA, CVS, RAD

Visit the podcast's native language site